Page 3 - Benjamin Cryer News Today

Ct Automotive Regulatory News. Live CTA RNS. Regulatory News Articles for Ct Automotive Group Plc Ord Gbp0.005

Investegate announcements from M&C Saatchi PLC, Update regarding possible offer

Investegate announcements from M&C Saatchi PLC, Closure of FCA Investigation and Trading Update

Investegate announcements from M&C Saatchi PLC, Holding(s) in Company

UK E&P company focused on building an upstream oil and gas business in the North Sea. The Company holds a significant acreage position within the Central North Sea referred to as the Greater Buchan Area ("GBA"), which includes operatorship and 100% working interests in blocks that contain the Buchan oil field and J2 and Glenn oil discoveries and an 100% working interest in the P2170 Licence Blocks 20/5b & 21/1d, that contain the Verbier oil discovery and other exploration prospects. JOGs tota...

Investegate announcements from Jersey Oil & Gas PLC, Result of AGM

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any natio...

("Jersey Oil & Gas", "JOG" or the "Company")     Jersey Oil & Gas (AIM:JOG), an independent upstream oil and gas company ‎focused on the UK Continental Shelf region of the North Sea, announces that it will today post to shareholders copies of its Annual Report and Accounts for the year ended 31 December 2020 together with the Notice of Annual General Meeting ("AGM") and Form of Proxy. An electronic copy of these documents will also be made available on ...

  and   The Board of SEC Newgate (AIM: SECN), the insight-driven global strategic communications group that works at the nexus of business, politics, communities, markets and media, is pleased to provide an update on results (unaudited) for the year ended 31 December 2020.   · Gross Profit of €56.1m  (2019: €37.6m) · Profit before Tax of €3.0m  (2019: €1.3m) · Group net Debt (at 31 December 2020) of €...

  Open Orphan plc  (London and Euronext: ORPH) is a rapidly growing pharmaceutical service/contract research company that is a world leader in testing vaccines and antivirals using human challenge clinical trials. The company provides services to Big Pharma, biotech and government/public health organisations.   Open Orphan runs challenge studies in London from both its 19-bedroom Whitechapel quarantine clinic, opened in February 2021, and its 24-bedroom QMB clinic ...